Evofem Bio launches Phase 2b/3 study evaluating STD-prevention effect of Amphora [Seeking Alpha]
Evofem Biosciences, Inc. (EVFM)
Last evofem biosciences, inc. earnings: 3/12 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
evofem.com
Company Research
Source: Seeking Alpha
Evofem Bio launches Phase 2b/3 study evaluating STD-prevention effect of AmphoraEnrollment isunderway in a Phase 2b/3 clinical trial, AMPREVENCE, assessing Evofem Biosciences' (EVFM) Amphora for the prevention of urogenital chlamydia and gonorrhea in women.AMPREVENCE will enroll up to ~850 women across as many as 20 U.S. sites. The primary endpoint is the prevention ofChlamydia trachomatis infection. The prevention ofNeisseria gonorrhoeae infection is a secondary endpoint.A Phase 3 study, AMPOWER, evaluating the pregnancy prevention effect of Amphora Contraceptive Vaginal Gel will be fully enrolled next month. Topline data should be available in Q1 2019.Amphora is an on-demand, non-hormonal, surfactant-free drug being developed as a vaginal contraceptive and for the prevention of certain sexually transmitted diseases (STDs). It has Qualified Infectious Disease Product (QIDP) status in the U.S. for the prevention of urogenital gonorrhea in women and for the reduction in re-occurrence o
Show less
Read more
Impact Snapshot
Event Time:
EVFM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EVFM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EVFM alerts
High impacting Evofem Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
EVFM
Sec Filings
- 3/28/24 - Form 8-K
- 3/27/24 - Form 10-K
- 3/27/24 - Form 8-K
- EVFM's page on the SEC website